About Kentreck
Kentreck is a Healthcare company based in India. Pharmaceutical manufacturing, therapeutic molecules, and quality control services in India. The company has 16 employees. Its Indian entity Kentreck Laboratories Pvt Ltd reported revenue of ₹17.30 Cr. Kentreck offers products and services including Oral Antibiotics and Analgesic and Anti-Inflammatory Drugs. Its focus areas include Pharmaceuticals, Drug Manufacturing, Therapeutic Molecules and Quality Control and Infrastructure.
Company details
The company was established in 1989 as a Private Limited entity under the companys act, operating as a fully-integrated pharmaceutical manufacturer based in Ahmedabad, Gujarat, India. It is committed to addressing global healthcare needs by producing safe, effective, and affordable medicines through the manufacturing and marketing of therapeutic molecules across multiple categories. A vision for global presence is pursued, supported by a professional team focused on transparency in finance, manufacturing, and regulatory aspects. State-of-the-art facilities and stringent quality controls are maintained to ensure product responsibility throughout the lifecycle, from development to packaging.
- Headquarters India
- Employees 16
- SectorsHealthcare
- Email••••••••
- Website kenlab.in
- Legal Name Kentreck Laboratories Private Limited
- Date of Incorporation 10 May, 1989
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹17.30 Cr
FY 2025 · 0% YoY
- Net Loss-₹3 Lakh
FY 2025 · 0% margin
- EBITDA₹1.21 Cr
FY 2025 · 7% margin
- Employee Count16
Associated legal entities of Kentreck
Kentreck operates through Kentreck Laboratories Pvt Ltd (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Kentreck Laboratories Pvt Ltd CIN U24231GJ1989PTC012216 | Active | 10 May 1989 | Ahmedabad, Gujarat | ₹17.3 Cr | 16 | 2 | View details |
Products & Services of Kentreck
Kentreck offers a comprehensive portfolio of products and services, including Oral Antibiotics and Analgesic and Anti-Inflammatory Drugs.
Oral antibiotics are manufactured and marketed for therapeutic uses across various categories.
Analgesic and anti-inflammatory drugs are produced and distributed as part of the therapeutic molecules portfolio.
Board of directors of Kentreck Laboratories Pvt Ltd (Kentreck)
Kentreck Laboratories Pvt Ltd is the primary company behind Kentreck. The board of Kentreck Laboratories Pvt Ltd currently have 2 directors; the longest-serving is Kenil Jaykantbhai Shah, appointed in 2019. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kenil Jaykantbhai Shah DIN 03264690 | Director | 11 Apr 2019 | 7 yrs 6 mo | Kentreck Laboratories Pvt Ltd |
| Monil Hirenkumar Doshi DIN 08172278 | Additional Director | 03 Feb 2025 | 1 yr 9 mo | Kentreck Laboratories Pvt Ltd |
Financials of Kentreck
Figures of Kentreck Laboratories Pvt Ltd, the primary company behind Kentreck, for FY 2025. Revenue was ₹17.30 Cr (0% year on year). Net loss was -₹3 Lakh (0% margin). EBITDA was ₹1.21 Cr (7% margin). Revenue has grown at a compounded annual rate of +11% over three years and +14% over five years.
- ₹17.30 CrRevenue · FY 2025 · 0% YoY
- -₹3 LakhNet loss · 0% margin
- ₹1.21 CrEBITDA · 7% margin
- ₹2.00 CrPaid-up capital
- 16Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- +14%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Kentreck Laboratories Pvt Ltd are on its company page.
Detailed financial statements for Kentreck
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kentreck
Kentreck is headquartered in India.
Kentreck has 16 employees.
The primary company behind Kentreck, Kentreck Laboratories Pvt Ltd, reported revenue of ₹17.30 Cr for FY 2025, down 0% year on year.
The company was established in 1989 as a Private Limited entity under the companys act, operating as a fully-integrated pharmaceutical manufacturer based in Ahmedabad, Gujarat, India. It is committed to addressing global healthcare needs by producing safe, effective, and affordable medicines through the manufacturing and marketing of therapeutic molecules across multiple categories. A vision for global presence is pursued, supported by a professional team focused on transparency in finance, manufacturing, and regulatory aspects. State-of-the-art facilities and stringent quality controls are maintained to ensure product responsibility throughout the lifecycle, from development to packaging.
Kentreck offers Oral Antibiotics and Analgesic and Anti-Inflammatory Drugs.
Kentreck operates through Kentreck Laboratories Pvt Ltd.
The legal entities of Kentreck currently have 2 directors, including Monil Hirenkumar Doshi, Kenil Jaykantbhai Shah.